Work Experience

Dr. KV Sajeevan gained international experience at the Cancer Center in Kuwait.
With a background in Internal Medicine, he brings a comprehensive approach to patient care. To further enhance his skills and knowledge, Dr. Sajeevan pursued additional training in the United Kingdom
Currently, Dr. Sajeevan is the Head of the Department of Medical Oncology at MVRCCRI, where he is known for his compassionate care and commitment to advancements in the field.
In addition to his medical expertise, Dr. KV Sajeevan possesses a creative side as a talented artist. His passion for art extends beyond the realm of medicine, demonstrating his diverse range of talents and interests.

• Gastro Intestinal
• HIPEC
• Hepato, pancreaticobiliary
• Head and Neck

• Review article A. Jain, KV.Sajeevan, KG.Babu, KC.Lakshmaiah Chemotherapy in adult soft tissue sarcoma Review article. Indian Journal of Cancer 2009; Vol.46:274-87
• 2. Tejinder Singh, KV Sajeevan, Ankit Jain, Ullas Batra, KS Saini, CT Satheesh, KC Lak-shmaiah, K Govind Babu, D Lokanatha Blindness as an initial presentation of rectal cancer with brain metas- tases. Saudi journal of gastroenterology2009:vol.15:1;63-64.
• 3. Singh Tejinder, Premalata CS, Sajeevan KV, Jain Ankit, Batra Ullas, Saini KS, Satheesh CT, Babu K Govind, Lokanatha Ig A plasma cell leukemia -case report. Journal of laboratory Physi-cians. 2009;vol.1:7.
• K.V. Sajeevan, K. C. Lakshmiah, A. Rani, T. M. Suresh, J Ankit, K. Saini, S. Batra, G. Anupama. The efficacy, toxicity profile and tolerability of cisplatin plus 5-FU versus docet-axel plus carbo- platin as induction therapy in locally advanced oral cancer: An experience from a tertiary cancer centre from South India. J Clin Oncol 26: 2008 (May 20 suppl; abstr 17017).
• 5. A. Jain, PP. Bapsy, L. Dasappa, G. Babu, U. Batra, KV. Sajeevan, K. Saini, T. Singh, S. At-tili. Nail changes induced by weekly paclitaxel as a surrogate marker for response assessment in patients with metastatic breast cancer J Clin Oncol 26: 2008 (May 20 suppl; abstr 12019)
• 6. T. Singh, KV. Sajeevan, C. T. Satheesh. Use of long term venous access in cancer patients: Ex- perience from a tertiary cancer centre in South India. J Clin Oncol 26: 2008 (May 20 suppl; abstr 20710)
• Attili SV, Jain A, Saini KV, Batra U, Govind Babu K, Sajeevan KV, Biswas S. Orbital metastasis: a rare presentation of osteosarcoma. Int Ophthalmol. 2008 Dec; 28(6):433-6
• 8. U. Batra, P. P. Bapsy, H. Dadhich, A. Suresh, K. S. Saini, K. G. Babu, D. Lokanatha, A. Jain, KV. Sajeevan. Efficacy, tolerability, toxicity profile and pharmaco-economics of 5-FU/LV versus FOLFOX IV as first line therapy in treatment of patients with metastatic col-orectal carcinoma, Ab- stract 391 Gastrointestinal Cancers Symposium ASCO 2007.
• 9. U. Batra, P. P. Bapsy, H. Dadhich, A. Suresh, K. S. Saini, K. G. Babu, D. Lokanatha, A. Jain, KV Sajeevan. Age dependent variability in interaction of hormone receptors and HER2 neu and its prognostic implication in early breast cancer: A retrospective analysis in South Indian women. Pro- ceedings of St.Gallens Breast Symposium-2007. The Breast; 2007; S1: Pg-s28 (abstract no P56)
• U. Batra, L. Dasappa, K. C. Lakshmiah, K. Babu, K. Saini, A. Jain, KV. Sajeevan, T. Singh, PP. Bapsy. Dose escalation of imatinib in CML patients with sub-optimal response to conventional dosage: Is it worth it? J Clin Oncol 26: 2008 (May 20 suppl; abstr 18026.
• Ankit Jain, Premalata C.s, Saini K.s, Bapsy P.p, Sajeevan KV, Tejinder Singh, Ullas Batra, Babu Govind, Lokanatha Dasappa, Suresh Atilli, Permeshwar R Acute myeloid leukemia following ra- dioactive iodine therapy for papillary carcinoma of thyroid article in press Turkish journal of hematology.
• A. Jain, P. Bapsy, S. V. Attili, U. Batra, L. Dasappa, K. Govindbabu, K. Sajeevan, KV. Saini and A. G. Variation in prognostic factors in hormone receptor-positive breast cancer patients who re- sponded to hormonal therapy and those who did not: A retrospective analysis Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings, Vol 25, No 18S (June 20 Supplement), 2007: 11514.
• U. Batra, L. Dasappa, K. C. Lakshmiah, K. Babu, K. Saini, A. Jain, KV. Sajeevan, HER2 expres- sion and response to endocrine treatment in advanced breast cancer- Is there an age differential? Proceedings of St. Gallen Breast Symposium-2007. The Breast; 2007; S1: Pg-s46 (abstract no P116).

• MBBS : September1990 – February1996 Govt.Medical College Calicut, Kerala, India.Calicut University
• MD General Medicine: 1998 – March2001 Jawaharlal Institute of Postgraduate Medical Education and Research(JIPMER),Pondicherry,
  India.
  Pondicherry University
• DM Medical Oncology: 2006-July2009 Kidwai Memorial Institute of Oncology, Bangalore, Karnataka,India

Additional Qualifications:

• Certificate Course in Palliative Care 2009
  Indian Academy of Palliative Care
• Clinical Research Training 2009 NIH
• European Society of Medical Oncology Fellowship- 2014

• DPYD guidelines working committee member MASCC